Rapid increase in intravenous iron therapy for women of reproductive age in Australia

Antonia W. Shand, Jane Bell, Amanda Henry, Luke E. Grzeskowiak, Giselle Kidson-Gerber, Sallie Pearson, Natasha Nassar

Research output: Contribution to journalLetterpeer-review

15 Citations (Scopus)


We investigated the use of intravenous iron by women of reproductive age, analysing dispensing data for a 10% random sample of Australians eligible to receive subsidised medicines under the Pharmaceutical Benefits Scheme (PBS).3 We included data for all women aged 18–44 years with a dispensing claim for intravenous iron during January 2013 to December 2017. Three preparations were available: iron polymaltose and iron sucrose during 2013–2017, and ferric carboxymaltose from June 2014. We calculated the annual number and rate of intravenous iron dispensing claims and iron preparation types by age group, using Australian Bureau of Statistics 2017 population data,4 and estimated overall dispensing rates by extrapolating these numbers to the national level (Supporting Information). The study was approved by the New South Wales Population and Health Services Research Ethics Committee (reference, 2013/11/494) and the federal Department of Human Services External Request Evaluation Committee.
Original languageEnglish
Pages (from-to)85-86
Number of pages2
JournalMedical Journal of Australia
Issue number2
Publication statusPublished - 1 Jul 2020
Externally publishedYes


  • Iron deficiency anemias
  • Population health
  • Women’s health


Dive into the research topics of 'Rapid increase in intravenous iron therapy for women of reproductive age in Australia'. Together they form a unique fingerprint.

Cite this